“…In particular, the variation of N/O donor functionalities yielded several binucleating ligands containing {[N 3 O], [N 3 O]}, 25,30,31 {[N 3 O], [N 2 O 2 ]}, 32−42 {[N 3 O], [NO 3 ]}, 43,44 {[N 3 O], [N 2 O]}, 26 {[N 2 O 2 ], [NO 3 ]}, 24 and {[N 2 O 2 ], [N 2 O]} 45−47 donor sites that successfully stabilized a large number of hetero-dinuclear M(II)–M′(III) [M(II) = Fe(II), Mn(II), Zn(II), Cu(II), Co(II), and Ni(II) and M′(III) = Fe(III) and Ga(III)] cores mimicking the PAP enzyme active site. Of these, notable are the {[N 3 O], [N 2 O 2 ]} ligand systems containing Zn(II)–Fe(III), 18,35,39 Co(II)–Fe(III), 32,34 Cu(II)–Fe(III), 33,36 Mn(II)–Fe(III), 38 and Ni(II)–Fe(III) 37 cores and the {[N 2 O 2 ], [N 2 O]} ligand systems containing Zn(II)–Fe(III), Co(II)–Fe(III), Mn(II)–Fe(III), and Ni(II)–Fe(III) 45−47 cores that exhibited high PAP activities.…”